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Context: Breastfed infants rely on adequate maternal dietary iodine 
intake. 
Objective: Our objective was to measure breast milk iodine and 
perchlorate, an inhibitor of iodide transport into the thyroid and 
potentially into breast milk, in Boston-area women. 
Participants: The study included 57 lactating healthy volunteers in 
the Boston area. 
Measurements: Breast milk iodine and perchlorate concentrations 
and urine iodine, perchlorate, and cotinine concentrations were mea­
sured. For comparison, iodine and perchlorate levels in infant for­
mulae were also measured. 
Results: Median breast milk iodine content in 57 samples was 155 
µg/liter (range, 2.7–1968 µg/liter). Median urine iodine was 114 µg/liter 
(range, 25–920 µg/liter). Perchlorate was detectable in all 49 breast milk 
samples (range, 1.3–411 µg/liter), all 56 urine samples (range, 0.37–127 
µg/liter), and all 17 infant formula samples (range, 0.22–4.1 µg/liter) 
measured. Breast milk iodine content was significantly correlated with 
urinary iodine per gram creatinine and urinary cotinine but was not 
significantly correlated with breast milk or urinary perchlorate. 
Conclusions: Perchlorate exposure was not significantly correlated 
with breast milk iodine concentrations. Perchlorate was detectable in 
infant formula but at lower levels than in breast milk. Forty-seven 
percent of women sampled may have been providing breast milk with 
insufficient iodine to meet infants’ requirements. (J Clin Endocri­
nol Metab 92: 1673–1677, 2007) 
THYROID HORMONE, REQUIRING adequate iodine in­take, is critical for neurodevelopment in utero and in early 
life. Worldwide, iodine deficiency remains the leading cause of 
preventable mental retardation (1). Since the 1920s, U.S. dietary 
iodine has generally been adequate. However, among U.S. 
women of childbearing age (15–44 yr), median urinary iodine 
levels, a biomarker for dietary iodine, decreased by over 50% 
from 1971–1994 according to data from the National Health and 
Nutrition Examination Survey (NHANES) (2). More recent 
NHANES data indicate that urinary iodine levels have stabi­
lized (3). Although the latest NHANES study demonstrated an 
adequate median urinary iodine level of 167.8 µg/liter in U.S. 
adults, 16.8% of U.S. women of childbearing age had urinary 
iodine concentrations of less than 50 µg/liter (3). In our pop­
ulation at Boston Medical Center, we have reported that 9% of 
100 women sampled had urinary iodine levels below 50 µg/ 
liter, and 49% had values below that recommended for preg­
nant women (4). Breastfed infants are reliant on adequate ma­
ternal dietary iodine intake (5). The Institute of Medicine’s 
recommended dietary allowance for lactating women is 290 µg 
iodine daily (6). Based on concerns about adequate iodine in-
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take in the perinatal period, the National Academy of Sciences 
recently recommended that consideration be given to adding 
iodine to all prenatal vitamins (7). The American Thyroid As­
sociation has also recently recommended that all women re­
ceive 150 µg iodine supplements daily during pregnancy and 
lactation and that all prenatal vitamins contain 150 µg iodine (8). 
Perchlorate is an anion that decreases the uptake of iodine 
into the thyroid gland and potentially into milk ducts in the 
lactating breast by competitively inhibiting the sodium/iodide 
symporter (NIS) on the basolateral surface of thyroid cells and 
on lactating breast cells. Perchlorate is a component of solid 
rocket fuel, is found in Chilean nitrate fertilizers used in the 
United States, and is an environmental contaminant from nat­
ural processes in many regions of the United States. Perchlorate 
has been detected in the drinking water of communities around 
the United States (9), including Massachusetts (10). It has also 
been detected in foods such as lettuce and wheat (11, 12). Per­
chlorate exposure appears to be ubiquitous in the U.S. popu­
lation (13). A recent study measured perchlorate in the breast 
milk of 36 women from 18 states and found detectable levels in 
all of the samples (range, 0.6–2.2 µg/liter) (14). Breast milk 
iodide and perchlorate concentrations were inversely corre­
lated in the six samples with perchlorate concentrations of at 
least 10 µg/liter, although there were no correlations between 
breast milk iodide and perchlorate in the full data set (14). 
Another recent study concluded that cigarette smoking 
decreases breast milk iodine concentrations (15). Cigarette 
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smoke contains significant levels of cyanide that is metab­
olized to thiocyanate, a known competitive inhibitor of the 
NIS. Elevated serum thiocyanate levels may inhibit NIS-
mediated transport of iodide in the lactating breast, leading 
to reduced breast milk iodine levels. 
The objective of the present study was to determine 
whether breast milk iodine concentrations in Boston-area 
women are adequate for infant nutrition and whether breast 
milk iodine concentrations may be associated with environ­
mental perchlorate or cigarette smoke exposure. Levels of 
iodine and perchlorate in breast milk were compared with 
those measured in 17 brands of infant formulae. 
Subjects and Methods 
We obtained breast milk and urine samples from 57 healthy Boston-
area volunteers (range, 19 –45 yr; mean age, 30 ± 6 yr), at 10–250 
(median, 48) days postpartum, between July 2002 and April 2006. The 
local Institutional Review Board approved the protocol, and informed 
consent was obtained from all participants. Volunteers were recruited 
through various means, including a community-based new mothers’ 
group, routine postpartum visits at a hospital-based inner-city obstetric 
clinic, and flyers posted in a hospital lobby. Of the women studied, 72% 
reported taking prenatal multivitamins, but only three were using io­
dine-containing multivitamin preparations. 
Twenty-seven women completed a questionnaire regarding their de­
mographics and intake of dietary iodine and iodine-containing multi­
vitamins. Spot urinary iodine measurements were obtained from all 
subjects. Urine perchlorate, creatinine, and cotinine (a metabolite of 
nicotine in cigarette smoke) concentrations were also measured. Samples 
of breast milk (approximately 10 ml) were collected at the start of a feed 
using either hand expression or a breast pump in 27 of the women. 
Samples of breast milk were collected in 5-ml increments sequentially 
using a breast pump in the other 30 women. In this subset of 30 subjects, 
we measured breast milk iodine concentrations both at the start of a feed 
and sequentially throughout a single feed to assess any potential in­
trafeed variation. In the women whose breast milk was collected in 
sequential increments, the mean breast milk iodine concentration is 
reported. Enough breast milk was available in 49 (86%) and enough 
urine was available in 56 (98%) of the samples for the measurement of 
perchlorate. Enough urine was available in 56 (98%) of the samples for 
the measurement of cotinine. All breast milk and urine samples were 
obtained within the same hour. 
Seventeen brands of infant formulae were also assessed for iodine and 
perchlorate levels. A single sample of each different type of liquid 
formula available at a local supermarket was purchased for testing. Nine 
brands were sold in concentrated form and designed to be diluted by 
half before use. Iodine and perchlorate levels were measured directly in 
these samples, and the results were divided by half to reflect the con­
centration intended for infant use. The other eight brands were sold 
ready for use. 
Breast milk, infant formulae, and urine iodine concentrations were 
measured spectrophotometrically by a modification of the method of 
Benotti et al. (16). Iodine concentrations were measured at least twice; in 
95% of the samples, the initial two measurements were within 15% of 
each other, and the two values were averaged. In the case where the 
initial two measurements were not within 15% of each other, a third 
measurement was obtained, and the average of all measurements was 
reported. Cotinine measurements were performed by immunoassay 
(Immulite 2000 Nicotine Metabolite Assay; Diagnostic Products Corp., 
Los Angeles, CA). Urine creatinine measurements were performed us­
ing Jaffe’s alkaline picrate method. The perchlorate content of breast 
milk, infant formulae, and urine samples was measured at the Centers 
for Disease Control and Prevention laboratories in Atlanta, GA, using 
ion chromatography-mass spectrometry (17). 
All statistical analyses were carried out using SAS version 9.1 (SAS 
Institute, Cary, NC). Spearman’s rank correlation coefficient was used 
to determine whether linear associations were present, and multivariate 
linear regression was used to determine significant predictors of breast 
milk iodine concentration. Intrafeed variation in the iodine content of the 
subjects whose breast milk was measured sequentially was assessed 
using repeated-measures ANOVA. Differences in breast milk and urine 
iodine values between smokers and nonsmokers and differences in 
measured and labeled infant formula iodine content were assessed using 
an independent t test. Differences in mean values across subject groups 
were assessed by ANOVA. Differences in median iodine and perchlorate 
values in breast milk compared with infant formula were assessed using 
the Wilcoxon rank sum test. 
Results 
Median iodine content in the 57 breast milk samples was 
155 µg/liter [range, 2.7–1968 µg/liter; mean (± sd), 205 ± 
271 µg/liter]. There was no significant intrafeed variation in 
the iodine content of the subjects whose breast milk was 
assessed sequentially during a single feed. Breast milk iodine 
concentrations in the three women who reported using io­
dine-containing multivitamins were 28, 68, and 187 µg/liter. 
In a subset of 27 women whose use of iodized table salt was 
determined, there was no significant difference in breast milk 
iodine levels between the subjects who reported regular, 
occasional, or no use of iodized salt (P = 0.16). There was a 
slight but significant positive correlation between breast milk 
iodine content and maternal age (r2 = 0.08; P = 0.04) but not 
infant age (P = 0.4). Median urine iodine content was 114 
µg/liter (range, 25–920 µg/liter; mean, 155 ± 142). 
Perchlorate was detectable in all 49 breast milk samples (me­
dian, 9.1 µg/liter; range, 1.3–411; mean, 33 ± 77) and 56 urine 
samples tested (median, 3.0 µg/liter; range, 0.37–127; mean, 
8.2 ± 19). Cotinine was detected in the urine of 32 (57%) of 56 
urine samples tested (range, 1.5–1575 ng/ml), with six (19%) of 
these likely to be smokers (urinary cotinine >500 ng/ml). Mean 
breast milk iodine was 62 ± 35 µg/liter in the smokers and 
221 ± 285 µg/liter in the nonsmokers (P = 0.0005), whereas 
urinary iodine did not differ between these groups (P = 1.0). 
There were significant differences in the mean breast milk per­
chlorate concentrations between the women recruited from the 
mothers seen at routine postpartum visits at a hospital-based 
inner-city obstetric clinic (n = 10; 88.0 ± 150.0 µg/liter), those 
from the community-based new mothers’ group (n = 9; 50.0 ± 
62.5 µg/liter), and those recruited by the hospital postings (n = 
30; 10.3 ± 13.8 µg/liter) (P for difference across the three groups 
was 0.01). There were no significant differences between breast 
milk iodine, urinary iodine, urinary perchlorate, and urinary 
cotinine across these subject groups. 
Breast milk and urine iodine content in micrograms per 
liter were not significantly correlated (r2 = 0.06; P = 0.08). A 
significant positive correlation between breast milk iodine 
and urine iodine content per gram creatinine was observed 
(r2 = 0.27; P < 0.0001). There was a significant positive 
correlation between breast milk perchlorate and urine per­
chlorate concentrations (r2 = 0.11; P = 0.02). There were no 
significant correlations between breast milk iodine and per­
chlorate concentrations (n = 49; r2 = 0.05; P = 0.1) (Fig. 1), 
including the 23 women whose breast milk perchlorate val­
ues were 10 µg/liter or higher (r2 = 0.002; P = 0.8). Breast 
milk iodine and urine perchlorate concentrations (r2 = 0.004; 
P = 0.7) were not significantly correlated. There was a slight 
but significant inverse correlation between breast milk iodine 
and urine cotinine concentrations (r2 = 0.13; P = 0.006) (Fig. 
2). In multivariate models, breast milk perchlorate (P = 0.9), 
urine perchlorate (P = 0.4), urine cotinine (P = 0.2), and baby 
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FIG. 3. Mean breast milk iodine content by quartile, with SD shown 
numerically. Dotted line corresponds to approximate breast milk io­
dine content required to achieve adequate intake (110–130 µg/liter) 
for an infant age 0 –6 months. 
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FIG. 2. Correlation between breast milk iodine and urine cotinine 
concentrations. 
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 500
age (P = 0.6) did not predict breast milk iodine levels. As­
suming an average daily infant intake of 0.78 liters breast 
milk (1) and that these breast milk samples are representa­
tive, 27 of the 57 samples (47%) did not contain sufficient 
iodine to meet infants’ adequate intake of 110–130 µg/d, as 
recommended by the Institute of Medicine (Fig. 3). 
In the 17 brands of infant formulae, the median measured 
iodine concentration was 145 µg/liter (range, 84–224 µg/liter), 
and the median perchlorate concentration was 1.50 µg/liter 
(range, 0.22–4.1 µg/liter) (Table 1). Measured infant formula 
iodine concentrations were significantly higher than labeled 
amounts (P < 0.0001). There was no significant difference be­
tween the median breast milk and infant formula iodine con­
centrations (P = 1.0), whereas the median breast milk perchlor­
ate concentration was significantly higher than the median 
infant formula perchlorate concentration (P < 0.0001). 
Discussion 
Iodine is avidly concentrated in the lactating breast, due to 
increased expression of NIS during lactation (18). Breast milk 
iodine levels are highest in transitional milk (2–5 d postpar­
tum) and decrease to stable levels by 10 d postpartum (18). 
We report that among the 30 subjects whose breast milk was 
sampled sequentially, there were no significant intrafeed 
variations in iodine concentration. A recent study suggests, 
however, that there is a substantial amount of day-to-day 
and diurnal variation in breast milk iodine excretion (19). 
The median breast milk iodide level in a 1984 sample of 37 
U.S. women was 178 µg/liter (20), which is similar to the 
median iodine value of 155 µg/liter observed in our study. 
However, the median breast milk iodine value in our study 
was far higher than the median values of breast milk iodide 
(33.5 and 55.2 µg/liter) observed recently by Kirk et al. (14, 
19) in two samples of U.S. women. Some, but not all, of this 
difference may be due to our method of measuring total 
iodine in contrast to Kirk et al. (14, 19), who measured only 
ionic iodine (iodide); however, approximately 80 –90% of 
iodine in human milk is in the form of iodide (S. Pino, 
unpublished data). The median breast milk iodine concen­
tration observed in our study was also far higher than the 
mean value of 38.5 µg/liter reported in 55 Chilean women 
(21); the iodine content of breast milk from the Chilean 
women was measured by the same method as reported in the 
current manuscript (16). Tellez et al. (21) in the Chilean study 
and Chan et al. (22) in an Australian study reported that 
breast milk iodine levels correlate with urinary iodine per 
gram creatinine but not with unadjusted urinary iodine val­
ues, as seen in the present study. 
Assuming breast milk intake of 0.78 liter/d (6) as the only 
source of breastfed infant iodine nutrition, and that single 
samples are representative of daily breast milk iodine con­
tent, which may not be correct due to the day-to-day and 
diurnal variation in breast milk iodine content noted by Kirk 
et al. (19), 47% of women sampled may have been providing 
breast milk with insufficient iodine to meet infants’ daily 
requirements. The difference between median breast milk 
and measured infant formula iodine levels was not signifi-
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TABLE 1. Iodine and perchlorate concentrations in 17 brands of infant formulae 
Labeled iodine Measured iodine Measured perchlorate Liquid infant formula brand (µg/liter) (µg/liter) (µg/liter) 
Milk-based 
Enfamil A.R. Lipil (thickened with rice starch, iron-fortified) 67 224 4.1 
Enfamil LactoFree Lipil (lactose-free, iron-fortified)a 100 120 0.4 
Enfamil Lipil Low Iron 67 158 2.1 
Enfamil Lipil with Iron (infant formula)a 67 102 1.7 
Enfamil with Iron (milk-based)a 67 162 2.0 
Nestle Good Start with Iron (Supreme, with easy to digest 80 145 0.3 
Comfort Proteins)a 
Nestle Good Start with Iron (Supreme, with easy to digest 80 178 0.2 
Comfort Proteins) 
Nutramigen Lipil (lactose-free, hypoallergenic, iron-fortified) 100 193 1.5 
Similac Advanced Infant Formula with Irona 40 122 1.5 
Similac Alimentum Advance with Iron (protein hydrolysate 100 158 2.0 
formula with iron, hypoallergenic) 
Similac Infant Formula Low Iron 40 153 2.1 
Similac Infant Formula with Irona 40 142 1.6 
Similac Lactose Free Infant Formula with Iron 60 143 1.4 
Similac Neosure Advance with Iron 100 178 2.5 
Soy-based 
Enfamil Prosobee Lipil (milk-free, lactose-free, iron-fortified)a 100 112 0.3 
Enfamil Prosobee Soy Infant Formula (milk-free, lactose-free, 100 122 0.6 
iron-fortified)a 
Similac Isomil Soy Formula with Iron (milk-free, lactose-free)a 100 84 0.4 
All of the iodine and perchlorate levels reported here reflect the concentration intended for infant use.
 
a The nine brands of infant formula that were sold in concentrated form and designed to be diluted by half before use.
 
cant (P = 1.0); however, there was a significant difference 
between the labeled and measured mean infant formula io­
dine concentrations (P < 0.0001). Assuming an average in­
fant formula intake of 0.86 liter/d (for infants 2 months of 
age) (23), the labeled iodine concentrations in all 17 (100%) 
infant formula brands were insufficient to meet the Institute 
of Medicine’s recommended adequate intake of 110 µg/d, 
whereas 35% of the measured infant formula iodine concen­
trations contained insufficient iodine levels. Although clin­
ically apparent iodine deficiency disorders are vanishingly 
rare in U.S. infants, it is possible that breast-fed infants whose 
mothers’ milk is iodine deficient, as well as some formula-fed 
infants, might experience subtle neurodevelopmental abnor­
malities. An upper limit for iodine tolerability has not been 
established in infants. 
The question of whether low-level environmental per­
chlorate exposure has clinical consequences has been ex­
tremely controversial (24) and has been the topic of a recent 
National Academy of Sciences review (7). Median urine per­
chlorate was 3.6 µg/liter in 2820 spot urine specimens in the 
most recent NHANES survey (2001–2002) (13), and there was 
a small positive correlation with serum TSH and a small 
inverse correlation with serum T4 values among women, but 
not men, with urinary iodine values less than 100 µg/liter 
(25). The developing fetus and infant are likely to be most 
vulnerable to the adverse effects of perchlorate on thyroid 
function because they have the highest rate of thyroidal 
iodine turnover and they require adequate thyroid hormone 
for normal neurodevelopment. In this study, we found mea­
surable perchlorate levels in 100% of 49 human milk samples 
tested, with a median value of 9.1 µg/liter. This is higher than 
the levels reported by Kirk et al. (14, 19) in two recent studies 
(medians, 3.3 and 4.0 µg/liter) and in the infant formulae 
currently measured (median, 1.50 µg/liter). There was a 
significant difference in the perchlorate levels among the 
subjects when grouped by method of recruitment, which 
may be attributable to the relatively small sample size as well 
as the demographic differences of the study population. In 
data from NHANES 2001–2002, non-Hispanic Blacks had 
lower levels of urinary perchlorate than non-Hispanic 
Whites (13). Perchlorate was also detectable in all 56 human 
urine samples tested, with median levels (2.90 µg/liter, and 
2.94 µg/g creatinine) consistent with previously published 
data (17). The source of this perchlorate exposure is unknown 
and merits further investigation. 
Kirk et al. (14) previously speculated that milk perchlorate 
of 10 µg/liter or higher may lead to reduced milk iodide 
levels. Despite the fact that 47% of our samples contained 
perchlorate at concentrations of at least 10 µg/liter, we found 
no correlations between milk perchlorate and milk iodine 
content. Our results are consistent with the results of Lenge­
mann (26), who found dairy cattle milk iodine excretion 
unaffected by perchlorate doses less than 0.1 mg/kg·d. A 
recent study of pregnant and lactating Chilean women con­
suming tap water known to contain naturally occurring per­
chlorate (�110 µg/liter) also found no correlation between 
perchlorate exposure and breast milk iodine or newborn 
thyroid function tests (21). One possible reason for the lack 
of correlation in these studies might be the diurnal and day­
to-day variation in breast milk concentrations of both iodine 
and perchlorate (19). 
Thiocyanate, as a metabolite of cigarette smoking, is also 
a known inhibitor of the NIS. Laurberg et al. (15) reported that 
although both smokers and nonsmokers had stable levels of 
urinary iodine postpartum, smokers (defined as those with 
urinary cotinine >500 ng/ml) had lower concentrations of 
breast milk iodine, and their infants had lower concentra­
tions of urinary iodine. Similarly, we found a small but 
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significant inverse correlation between breast milk iodine 
and urine cotinine concentrations and found that smokers 
had significantly lower breast milk iodine levels than non­
smokers. Breastfeeding women should clearly be counseled 
against smoking for this and many other reasons. 
We believe that a larger study of breast milk iodine content 
and its relationship to perchlorate exposure and maternal 
iodine nutrition is warranted in U.S. women. Although in the 
present study we found no correlation between breast milk 
iodine and perchlorate concentrations, the relatively low lev­
els of iodine and relatively high levels of perchlorate in 
human milk do raise concerns. One limitation of the study 
was that we do not know the impact of breast milk per­
chlorate on the thyroidal iodine uptake and thyroid function 
of the breastfed infants. The American Thyroid Association 
has recently identified as a research priority the measure­
ment of breast milk iodine levels in U.S. women and corre­
lation with maternal iodine nutrition and factors such as 
smoking (27). Very few women in the present study reported 
routine use of an iodine-containing multivitamin. We feel 
that there should be more public awareness of the impor­
tance of dietary iodine in lactation and that iodine (at least 
150 µg) should be included in standard prenatal multivita­
mins consistent with the recent recommendations of the Na­
tional Academy of Sciences (7) and the American Thyroid 
Association (8). It is important to note that epidemiological 
studies consistently point to the value of human milk as the 
healthiest food for infants. Thus, the benefits of human milk 
outweigh possible effects of environmental toxicants present. 
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